Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS.
JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847.
The complexity of Alzheimer's disease: an evolving puzzle.
Ferrari C, Sorbi S.
Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21.
Spatially resolved mass spectrometry analysis of amyloid plaque-associated lipids.
Blank M, Hopf C.
J Neurochem. 2021 Oct;159(2):330-342. doi: 10.1111/jnc.15216. Epub 2020 Nov 1.
Protein folding and misfolding.
Dobson CM.
Nature. 2003 Dec 18;426(6968):884-90. doi: 10.1038/nature02261.
Alzheimer's disease.
Blennow K, de Leon MJ, Zetterberg H.
Lancet. 2006 Jul 29;368(9533):387-403. doi: 10.1016/S0140-6736(06)69113-7.
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.
Karran E, De Strooper B.
Nat Rev Drug Discov. 2022 Apr;21(4):306-318. doi: 10.1038/s41573-022-00391-w. Epub 2022 Feb 17.
beta-Amyloid peptides and amyloid plaques in Alzheimer's disease.
Gouras GK, Olsson TT, Hansson O.
Neurotherapeutics. 2015 Jan;12(1):3-11. doi: 10.1007/s13311-014-0313-y.
Plaque fluid as a bacterial milieu.
Edgar WM, Higham SM.
J Dent Res. 1990 Jun;69(6):1332-6. doi: 10.1177/00220345900690062101.
Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.
Atwood CS, Martins RN, Smith MA, Perry G.
Peptides. 2002 Jul;23(7):1343-50. doi: 10.1016/s0196-9781(02)00070-0.
Shear-Induced Amyloid Formation in the Brain: IV. Effects on Synapses Surrounding Senile Plaque and in Plaque-Free Regions.
Trumbore CN.
J Alzheimers Dis. 2018;66(1):57-73. doi: 10.3233/JAD-171080.
